Faculty Member

Jennifer Brooks

Email Address(es)
jennifer.brooks(at)utoronto.ca
Office Phone
416-978-1785
Office Address
155 College St. HSB 676 Toronto, Ontario M5T 3M7
Division(s)/Institute(s)
Epidemiology Division
Position
Assistant Professor
SGS Status
Full Member
Appointment Status
Tenure Stream
Currently Accepting Doctoral Students?
Yes

Research Interests

  • breast cancer epidemiology
  • genetic epidemiology
  • contalateral breast cancer
  • survivorship
  • imaging biomarkers of breast cancer risk and response to treatment
  • risk prediction
  • breast cancer screening
  • pharmacogenetics
  • maternal exposures and neurodevelopment
  • autism spectrum disorder
  • ADHD

Education & Training History

  • PhD Epidemiology – New York University
  • MSc Nutritional Sciences – University of Toronto
  • BSc Biological Sciences – University of Guelph

Professional Summary & Appointments

  • 2014 Assistant Professor of Epidemiology – Dalla Lana School of Public Health, University of Toronto
  • 2014 Assistant Attending Level 1 – Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY NY USA
  • 2012-2014 Instructor – Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY NY USA
  • 2009-2012 Research Scholar – Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY NY USA

Primary teaching responsibilities

  • Categorical Data Analysis for Epidemiologists (CHL5407)
  • Epidemiology Methods 1 (CHL5401)
  • Supervision of graduate students

Ongoing research projects

  • Prediction of risk of cardiovascular disease in women diagnosed with early stage breast cancer. (CIHR funded: 2017-2019)
  • Developing tools that predict use of breast cancer screening and stage at breast cancer diagnosis. (CIHR funded: 2017-2019)
  • Province of Ontario neurodevelopmental Network (POND). (Ontario Brain Institute funded: 2018-2023)
  • Personalized risk assessment for prevention and early detection of breast cancer: Integration and Implementation (PERSPECTIVE I&I) (Genome Canada, Genome Quebec, Ontario Research Fund funded: 2018-2022)
  • MRI parenchymal enhancement and risk of breast cancer: A population-based study of women screened in the Ontario Breast Screening Program. (CIHR funded: 2017-2021)
  • Linkage of whole genome sequencing and administrative health data for the study of autism spectrum disorder (ASD). (McLaughlin Centre funded: 2017-2018)
  • Molecular pathoepidemiology of contralateral breast cancer. (US NCI funded: 2017-2021)
  • MRI background parenchymal enhancement as a risk factor for breast cancer. (US NCI funded: 2014-2017)
  • CYP2D6 phenotype, tamoxifen treatment and risk of contralateral breast cancer in the WECARE Study Population (Chanel Endowment to Fund Survivorship Research funded: 2014-2016)
  • Histopathologic Characteristics of MRI Background Parenchymal Enhancement as a Biomarker of Breast Cancer Risk (Survivorship Outcomes And Risk (SOAR) Developmental Funds Award (MSK) funded: 2015)
  • Tumor effects on the measurement of enhancement on breast MRI: Implications for study design. (MSK/Goldstein Family Foundation funded: 2014)

Brown, Adalsteinn
Brook, Jeffrey R.
Back to listing
Top
Brown, Adalsteinn
Brook, Jeffrey R.